{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:16:42Z","timestamp":1790551002648,"version":"4.1.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,8]]},"DOI":"10.18632\/oncotarget.6239","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T20:31:36Z","timestamp":1446237096000},"page":"42130-42149","source":"Crossref","is-referenced-by-count":41,"title":["Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival"],"prefix":"10.18632","volume":"6","author":[{"given":"Valentina","family":"Trimarco","sequence":"first","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ave","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Facco","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Chiodin","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Frezzato","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Martini","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gattazzo","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Lessi","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Giorgi","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Visentin","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Castelli","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Severin","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Zambello","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Piazza","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Semenzato","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Trentin","sequence":"additional","affiliation":[{"name":"Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"key":"1","first-page":"5149","article-title":"Chronic Lymphocytic Leukemia: Current Concepts","volume":"35","author":"Tabbara","year":"2015","journal-title":"Anticancer Res"},{"key":"2","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.181.4.1507","article-title":"Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells","volume":"181","author":"Chiorazzi","year":"1995","journal-title":"J Exp Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Stevenson","year":"1999","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia","volume":"100","author":"Stilgenbauer","year":"2002","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Montserrat","year":"2003","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Kipps","year":"2004","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V89.7.2516","article-title":"11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis","volume":"89","author":"Lichter","year":"1997","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Lichter","year":"2000","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/JCO.2006.08.3089","article-title":"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997","volume":"25","author":"Byrd","year":"2007","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1080\/10428190412331272703","article-title":"Microenvironmental interactions and survival of CLL B-cells","volume":"45","author":"Reed","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/asheducation-2011.1.96","article-title":"Nurturenature: the microenvironment in chronic lymphocytic leukemia","author":"Burger","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hoc.2013.01.002","article-title":"Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications","volume":"27","author":"Wiestner","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2012-08-452607","article-title":"Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling","volume":"121","author":"Montserrat","year":"2013","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2141.1996.00305.x","article-title":"Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells","volume":"92","author":"Hoffbrand","year":"1996","journal-title":"Br J Haematol"},{"key":"15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10428190290011921","article-title":"Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells","volume":"43","author":"Kipps","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.2009.07868.x","article-title":"Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression","volume":"147","author":"Kay","year":"2009","journal-title":"Br J Haematol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2009-09-242719","article-title":"Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression","volume":"115","author":"Kay","year":"2010","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3324\/haematol.2010.031377","article-title":"Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells: a dominant role of CCL2","volume":"96","author":"Seiffert","year":"2011","journal-title":"Haematologica"},{"key":"19","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-06-1204","article-title":"Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma","volume":"12","author":"Rafii","year":"2006","journal-title":"Clin Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.2007.14.5367","article-title":"Lenalidomide for the treatment of B-cell malignancies","volume":"26","author":"Cheson","year":"2008","journal-title":"J Clin Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/leu.2008.299","article-title":"CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers","volume":"23","author":"Peled","year":"2009","journal-title":"Leukemia"},{"key":"22","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood-2013-09-453092","article-title":"How will B-cell-receptor-targeted therapies change future CLL therapy?","volume":"123","author":"Byrd","year":"2014","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Byrd","year":"2011","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1073\/pnas.77.8.4756","article-title":"Long-term culture of human bone marrow cells","volume":"77","author":"Kaplan","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1634\/stemcells.2004-0331","article-title":"Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells","volume":"24","author":"Papamichail","year":"2006","journal-title":"Stem Cells"},{"key":"26","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","article-title":"Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2014current views","volume":"25","author":"Prockop","year":"2007","journal-title":"Stem Cells"},{"key":"27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Horwitz","year":"2006","journal-title":"Cytotherapy"},{"key":"28","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","article-title":"Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"29","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1038\/bcj.2012.17","article-title":"Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy","volume":"2","author":"Krampera","year":"2012","journal-title":"Blood Cancer J"},{"key":"30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI200522094","article-title":"Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis","volume":"115","author":"Donella-Deana","year":"2005","journal-title":"J Clin Invest"},{"key":"31","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood-2008-02-139139","article-title":"Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia","volume":"112","author":"Brunati","year":"2008","journal-title":"Blood"},{"key":"32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.seminhematol.2014.05.007","article-title":"The B-cell receptor pathway: a critical component of healthy and malignant immune biology","volume":"51","author":"Dubovsky","year":"2014","journal-title":"Semin Hematol"},{"key":"33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI7335","article-title":"The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis","volume":"104","author":"Semenzato","year":"1999","journal-title":"J Clin Invest"},{"key":"34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1189\/jlb.1203652","article-title":"Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination","volume":"76","author":"Munoz","year":"2004","journal-title":"J Leukoc Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"e23758","DOI":"10.1371\/journal.pone.0023758","article-title":"Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells","volume":"6","author":"Hartmann","year":"2011","journal-title":"PLoS One"},{"key":"36","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1182\/blood-2002-03-0844","article-title":"Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a","volume":"100","author":"Torok-Storb","year":"2002","journal-title":"Blood"},{"key":"37","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1182\/blood.V91.7.2387","article-title":"Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells","volume":"91","author":"Stryckmans","year":"1998","journal-title":"Blood"},{"key":"38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0301-472X(01)00612-9","article-title":"Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)","volume":"29","author":"Banker","year":"2001","journal-title":"Exp Hematol"},{"key":"39","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1038\/sj.onc.1210519","article-title":"Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a","volume":"26","author":"Bernard","year":"2007","journal-title":"Oncogene"},{"key":"40","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3109\/10428194.2012.666662","article-title":"Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia","volume":"53","author":"Johnston","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00277-011-1218-z","article-title":"Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma","volume":"90","author":"Brockhoff","year":"2011","journal-title":"Ann Hematol"},{"key":"42","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1182\/blood.V87.10.4382.bloodjournal87104382","article-title":"Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion","volume":"87","author":"Foa","year":"1996","journal-title":"Blood"},{"key":"43","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1182\/blood.V87.8.3327.bloodjournal8783327","article-title":"Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders","volume":"87","author":"Semenzato","year":"1996","journal-title":"Blood"},{"key":"44","article-title":"Cell Trafficking in Chronic Lymphocytic Leukemia","volume":"3","author":"Burger","year":"2012","journal-title":"Open J Hematol"},{"key":"45","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2011-05-352492","article-title":"The phosphoinositide 3\u2032-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia","volume":"118","author":"Burger","year":"2011","journal-title":"Blood"},{"key":"46","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Rai","year":"1996","journal-title":"Blood"},{"key":"47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Pasternack","year":"1975","journal-title":"Blood"},{"key":"48","doi-asserted-by":"crossref","first-page":"e39902","DOI":"10.1371\/journal.pone.0039902","article-title":"HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen","volume":"7","author":"Trentin","year":"2012","journal-title":"PLoS One"},{"key":"49","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","article-title":"Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6\/E7 genes","volume":"85","author":"Torok-Storb","year":"1995","journal-title":"Blood"},{"key":"50","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Kipps","year":"1999","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T18:23:13Z","timestamp":1589394193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,26]]},"references-count":50,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2015,12,8]]}},"alternative-id":["6239","26517523"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6239","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,26]]}}}